Molecule Structure

Scientific Name

Abacavir

Description of the Drug

Abacavir is an antiviral nucleoside reverse transcriptase inhibitor used in combination with other antiretrovirals for the treatment of HIV.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01048

Brand Name(s)

Ziagen

Company Owner(s)

Cipla Ltd, Apotex Inc, Laurus Labs Ltd, Viiv Healthcare Co, Hetero Labs Ltd Unit Iii, Aurobindo Pharma Ltd, Mylan Pharmaceuticals Inc, Teva Pharmaceuticals Usa, Strides Pharma Global Pte Ltd, Zydus Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Human immunodeficiency virus type 1 reverse transcriptase SINGLE PROTEIN INHIBITOR CHEMBL247

Unichem Links

SureChEMBL SCHEMBL38632
PharmGKB PA448004
Human Metabolome Database HMDB0015182
DrugBank DB01048
PubChem: Thomson Pharma 14775540 14799909
PubChem 441300
LINCS LSM-43340
Nikkaji J825.172J
PDBe 1KX
BindingDB 50366816
DrugCentral 34
ChemicalBook CB5698138
Guide to Pharmacology 11152
rxnorm ZIAGEN ABACAVIR SULFATE EPZICOM ABACAVIR
KEGG Ligand C07624
ChEBI 421707
ZINC ZINC000002015928